| BUIDX | VSMPX | BUIDX / VSMPX | |
| Total Expense Ratio | 0.79 | 0.02 | 3,950% |
| Annual Report Gross Expense Ratio | 0.79 | 0.02 | 3,950% |
| Fund Existence | 6 years | 11 years | - |
| Gain YTD | 9.056 | 17.371 | 52% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 177M | 2.06T | 0% |
| Annual Yield % from dividends | 1.13 | 1.12 | 101% |
| Returns for 1 year | 4.99 | 12.70 | 39% |
| Returns for 3 years | 52.92 | 70.86 | 75% |
| Returns for 5 years | 71.10 | 79.39 | 90% |
| Returns for 10 years | N/A | 230.39 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BPSCX | 26.68 | 0.35 | +1.33% |
| Boston Partners Small Cap Value II Inv | |||
| AIHHX | 6.13 | 0.07 | +1.16% |
| Aristotle Small/Mid Cap Equity I-2 | |||
| FBTAX | 39.02 | N/A | N/A |
| Fidelity Advisor Biotechnology A | |||
| SCAYX | 12.26 | -0.04 | -0.33% |
| Invesco Income Advantage U.S. Fund Y | |||
| LMGFX | 71.31 | -5.24 | -6.85% |
| ClearBridge International Growth FI | |||